Atlas Capital Advisors LLC Spero Therapeutics, Inc. Transaction History

Atlas Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$0.68 - $2.2 $494 - $1,599	727 New	727 $1.45 Million
Q2 2022 Aug 16, 2022	SELL	$0.74 - $7.44 $537 - $5,408	-727 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$12.22 - $15.79 $8,883 - $11,479	727 New	727 $10,000
Q1 2021 May 10, 2021	SELL	$13.23 - $21.48 $13 - $21	-1 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.65 - $22.07 $11 - $22	1 New	1 $0

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Capital Advisors LLC with notifications on news.